epidemiology

  1. SNT Gatchaman

    Incidence of long COVID and associated psychosocial characteristics in a large U.S. city, 2023, Tsai et al.

    Incidence of long COVID and associated psychosocial characteristics in a large U.S. city Tsai, Jack; Grace, Abigail; Espinoza, Rita; Kurian, Anita Purpose Persistent residual effects from Coronavirus Disease-2019 (COVID-19) have been observed with varying definitions of “Long COVID” and little...
  2. SNT Gatchaman

    Long-term health consequences among individuals with SARS-CoV-2 infection compared to individuals without infection, 2023, Heidemann et al.

    Long-term health consequences among individuals with SARS-CoV-2 infection compared to individuals without infection: results of the population-based cohort study CoMoLo Follow-up Heidemann, Christin; Sarganas, Giselle; Du, Yong; Gaertner, Beate; Poethko-Müller, Christina; Cohrdes, Caroline...
  3. Kalliope

    nature medicine - Postacute sequelae of COVID-19 at 2 years, 2023, Bowe, Xie, Al-Aly

    Abstract Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can lead to postacute sequelae in multiple organ systems, but evidence is mostly limited to the first year postinfection. We built a cohort of 138,818 individuals with SARS-CoV-2 infection and 5,985,227 noninfected...
  4. Andy

    Longterm course of neuropsychological symptoms and ME/CFS after SARS-CoV-2-infection: a prospective registry study 2023 Reuken et al

    Abstract A significant proportion of patients after SARS-CoV-2 infection suffer from long-lasting symptoms. Although many different symptoms are described, the majority of patients complains about neuropsychological symptoms. Additionally, a subgroup of patients fulfills diagnostic criteria for...
  5. Andy

    The importance of estimating prevalence of ME/CFS in future epidemiological studies of long COVID, 2023, Grabowska et al

    Abstract The resolution of the COVID-19 pandemic is giving rise to another public health challenge due to the explosion of long COVID (LC) cases. In many cases, LC results in persistent fatigue, post-exertional malaise (PEM), and other debilitating symptoms that resemble the clinical...
  6. SNT Gatchaman

    Long COVID and Significant Activity Limitation Among Adults, by Age — United States, June 1–13, 2022, to June 7–19, 2023, , Nicole D. Ford

    Long COVID and Significant Activity Limitation Among Adults, by Age — United States, June 1–13, 2022, to June 7–19, 2023 Nicole D. Ford et al. Long COVID is a condition encompassing a wide range of health problems that emerge, persist, or return following COVID-19. CDC analyzed national repeat...
  7. SNT Gatchaman

    Preprint Long COVID in a highly vaccinated population infected during a SARS-CoV-2 Omicron wave - Australia, 2022, 2023, Woldegiorgis et al.

    Long COVID in a highly vaccinated population infected during a SARS-CoV-2 Omicron wave - Australia, 2022 Mulu Woldegiorgis; Gemma Cadby; Sera Ngeh; Rosemary Korda; Paul Armstrong; Jelena Maticevic; Paul Knight; Andrew Jardine; Lauren Bloomfield; Paul Effler Objective: To characterise Long COVID...
  8. Sly Saint

    One-Year Follow-up of Young People with ME/CFS Following Infectious Mononucleosis by Epstein-Barr Virus, 2023 Scheibenbogen et al

    Preprint. Now published see post #6 Abstract Background: Infectious mononucleosis, caused by the Epstein-Barr Virus (EBV-IM), has been linked to the development of myalgic encephalomyelitis/chronic fatigue-syndrome (ME/CFS) in children, adolescents, and young adults. Our study presents the...
  9. Sly Saint

    Clinical phenotypes and quality of life to define post-COVID-19 syndrome: a cluster analysis of the multinational, prospective ORCHESTRA cohort, 2023

    Summary Background Lack of specific definitions of clinical characteristics, disease severity, and risk and preventive factors of post-COVID-19 syndrome (PCS) severely impacts research and discovery of new preventive and therapeutics drugs. Methods This prospective multicenter cohort study was...
  10. SNT Gatchaman

    Post COVID-19 symptoms are common, also among young adults in the general population, 2023, Mogensen et al.

    Post COVID-19 symptoms are common, also among young adults in the general population Mogensen, Ida; Ekström, Sandra; Hallberg, Jenny; Georgelis, Antonios; Melén, Erik; Bergström, Anna; Kull, Inger Post coronavirus disease-19 (post COVID-19) is mainly studied in clinical populations and less is...
  11. Sly Saint

    Review A systematic review and meta-analysis of long-term sequelae of COVID-19 2-year after SARS-CoV-2 infection: A call to action..., 2023, Rahmati et al

    A systematic review and meta-analysis of long-term sequelae of COVID-19 2-year after SARS-CoV-2 infection: A call to action for neurological, physical, and psychological sciences Abstract Long-term sequelae conditions of COVID-19 at least 2-year following SARS-CoV-2 infection are unclear and...
  12. SNT Gatchaman

    Recovery and symptom trajectories up to two years after SARS-CoV-2 infection: population based, longitudinal cohort study, 2023, Ballouz et al.

    Recovery and symptom trajectories up to two years after SARS-CoV-2 infection: population based, longitudinal cohort study Tala Ballouz; Dominik Menges; Alexia Anagnostopoulos; Anja Domenghino; Hélène E Aschmann; Anja Frei; Jan S Fehr; Milo A Puhan Objective To evaluate longer term symptoms and...
  13. SNT Gatchaman

    Systematic review of the prevalence of Long Covid, 2023 , Woodrow et al.

    Systematic review of the prevalence of Long Covid Woodrow, Mirembe; Carey, Charles; Ziauddeen, Nida; Thomas, Rebecca; Akrami, Athena; Lutje, Vittoria; Greenwood, Darren C; Alwan, Nisreen A Background: Long Covid occurs in those infected with SARSCoV2 whose symptoms persist or develop beyond the...
  14. Wyva

    Short and mid-term characteristics of COVID-19 disease course in athletes: A high-volume, single-center study, 2022, Juhász et al

    Abstract Introduction At the pandemic's beginning, significant concern has risen about the prevalence of myocardial involvement after SARS-CoV-2 infection. We assessed the cardiovascular burden of SARS-CoV-2 in a large cohort of athletes and identified factors that might affect the disease...
  15. Kalliope

    Socioeconomic determinants of ME/CFS in Norway: a registry study, Hilland and Anthun, 2023

    Now published - link here ******* Preprint Research Square Socioeconomic determinants of myalgic encephalomyelitis/chronic fatigue syndrome in Norway: a registry study Abstract Background: Previous research has shown that socioeconomic status (SES) is a strong predictor of chronic disease...
  16. Kalliope

    preprint medRxiv: COVID-19 illness severity and 2-year prevalence of physical symptoms: an observational study in Iceland, Sweden, Norway and Denmark

    by Shen et al, 2023 Abstract Background Persistence of physical symptoms after SARS-CoV-2 infection is a major public health concern, although evidence from large observational studies remain scarce. We aimed to assess the prevalence of physical symptoms in relation to acute illness severity...
  17. Mij

    Preprint medRxiv: Risk of new-onset Long Covid following reinfection with SARS-CoV-2: community-based cohort study, 2023 - Bosworth et al

    Abstract Background: Little is known about the risk of Long Covid following reinfection with SARS-CoV-2. We estimated the likelihood of new-onset, self-reported Long Covid after a second SARS-CoV-2 infection, and compared to a first infection. Methods: We included UK COVID-19 Infection Survey...
  18. SNT Gatchaman

    Prevalence and characteristics of long COVID in elderly patients: An observational cohort study of over 2 million adults in the US, 2023, Fung et al.

    Prevalence and characteristics of long COVID in elderly patients: An observational cohort study of over 2 million adults in the US Kin Wah Fung; Fitsum Baye; Seo H. Baik; Zhaonian Zheng; Clement J. McDonald Background Incidence of long COVID in the elderly is difficult to estimate and can be...
  19. T

    (CDC) Chronic Pain Among Adults — United States, 2019–2021, 2023, Rikard et al

    https://www.cdc.gov/mmwr/volumes/72/wr/mm7215a1.htm Chronic Pain Among Adults — United States, 2019–2021 Weekly / April 14, 2023 / 72(15);379–385 Print S. Michaela Rikard, PhD1; Andrea E. Strahan, PhD1; Kristine M. Schmit, MD1; Gery P. Guy Jr., PhD1 (VIEW AUTHOR AFFILIATIONS) View suggested...
  20. Kalliope

    Scientific reports: Prevalence of long COVID complaints in persons with and without COVID-19, 2023 - Magnusson, Flottorp et al

    Prevalence of long COVID complaints in persons with and without COVID-19 Abstract We studied the prevalence and patterns of typical long COVID complaints in ~ 2.3 million individuals aged 18–70 years with and without confirmed COVID-19 in a Nation-wide population-based prospective cohort study...
Back
Top Bottom